By Fineline Cube 
Shanghai MicroPort Endovascular MedTech Co., Ltd (SHA: 688016) announced that it has received marketing approval in Argentina for its Talos straight tube thoracic aortic stent graft system. This approval marks another milestone for the company’s innovative medical device in the global market.
Talos Stent System Features
The Talos stent, described as the world’s first “breathable” covered stent, was approved for marketing in China in 2022. It is specifically designed for the surgical treatment of Stanford B-type aortic dissection. The stent improves distal true lumen remodeling by extending the length of the stent. Its unique distal perforation structure, with a length selectable from 0-200mm, allows for the expansion of the distal true lumen of the thoracic aorta. This design reduces the risk of spinal cord ischemia caused by excessive coverage of intercostal arteries and enhances long-term treatment effectiveness.-Fineline Info & Tech